Issue 11/2020
Content (10 Articles)
On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19?
Kamal Desai, Eric Druyts, Kevin Yan, Chakrapani Balijepalli
Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
Risha Gidwani, Louise B. Russell
Integrative Review of Managed Entry Agreements: Chances and Limitations
Carolina Zampirolli Dias, Brian Godman, Ludmila Peres Gargano, Pâmela Santos Azevedo, Marina Morgado Garcia, Maurílio Souza Cazarim, Laís Lessa Neiva Pantuzza, Nelio Gomes Ribeiro-Junior, André Luiz Pereira, Marcus Carvalho Borin, Isabella de Figueiredo Zuppo, Roberto Iunes, Tomas Pippo, Renata Curi Hauegen, Carlos Vassalo, Tracey-Lea Laba, Steven Simoens, Sergio Márquez, Carolina Gomez, Luka Voncina, Gisbert W. Selke, Livio Garattini, Hye-Young Kwon, Jolanta Gulbinovic, Aneta Lipinska, Maciej Pomorski, Lindsay McClure, Jurij Fürst, Rosana Gambogi, Carla Hernandez Ortiz, Vânia Cristina Canuto Santos, Denizar Vianna Araújo, Vânia Eloisa Araujo, Francisco de Assis Acurcio, Juliana Alvares-Teodoro, Augusto Afonso Guerra-Junior
Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer
Erik F. Blom, Kevin ten Haaf, Harry J. de Koning
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Wei Gao, Dominic Muston, Matthew Monberg, Kimmie McLaurin, Robert Hettle, Elizabeth Szamreta, Elyse Swallow, Su Zhang, Iden Kalemaj, James Signorovitch, R. Brett McQueen
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
Michael Urbich, Gary Globe, Krystallia Pantiri, Marieke Heisen, Craig Bennison, Heidi S. Wirtz, Gian Luca Di Tanna
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome
Edward E. Neuberger, Josh J. Carlson, David L. Veenstra
Taking the Analysis of Trial-Based Economic Evaluations to the Next Level: The Importance of Accounting for Clustering
Mohamed El Alili, Johanna M. van Dongen, Keith S. Goldfeld, Martijn W. Heymans, Maurits W. van Tulder, Judith E. Bosmans
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data
Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro, Suzanne Kosmider, Rachel Wong, Belinda Lee, Matthew Burge, Jeanne Tie, Desmond Yip, Louise Nott, Adnan Khattak, Stephanie Lim, Susan Caird, Peter Gibbs, Maarten IJzerman
Correction to: Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers
Risha Gidwani, Louise B. Russell